This vaccine of corona increases the risk of heart disease, may cause death


This vaccine of corona increases the risk of heart disease, may cause death

There has been a shocking revelation about Corona’s messenger ribose nucleic acid (mRNA) vaccine. A recent study has revealed that mRNA is associated with an increased risk of cardiovascular death. Florida’s Surgeon General and State Health Officer Dr. Joseph A. Ladapo said the risk of cardiovascular death is particularly high in men between the ages of 18 and 39 from the mRNA vaccine.

Dr. Joseph tweeted, Today we are telling about the analysis of Kovid-19 mRNA Vaccine, about which people should be aware. He further said that analysis of mRNA vaccine found an 84% increase in the incidence of cardiovascular death in men aged 18-39 years within 28 days of vaccination.

He added that people with pre-existing cardiac conditions such as myocarditis and pericarditis should take special precautions when getting the vaccine. He further said, the study of the safety and efficacy of any drug or vaccine is an important component of public health. There has been little attention to safety regarding mRNA vaccines and many people’s concerns have been dismissed.

Messenger is RNA technology. This type of RNA is a sequence of DNA. This is the blueprint for making proteins. The mRNA in the mRNA vaccine carries the sequence information of the spike protein. The mRNA is covered by a lipid formulation. This is injected into the body. It makes spike proteins in the cells of the body. The spike protein makes antibodies to fight the corona.

In India, the emergency use of mRNA vaccine GEMCOVAC-19 from the Pune-based Genova Bio Pharmaceutical Company has been approved. The mRNA vaccine can be administered to people over the age of 18. The special thing is that the vaccine remains stable at 2 to 8 °C. It has five doses in one vial, which will be injected into the body through intramuscular injection. The second dose will be taken after an interval of 28 days after the first dose. PLC/GT


Please enter your comment!
Please enter your name here